Structural polymorphism of the low-complexity C-terminal domain of TDP-43 amyloid aggregates revealed by solid-state NMR

Structural polymorphism of the low-complexity C-terminal domain of TDP-43 amyloid aggregates revealed by solid-state NMR

Aberrant aggregation of the transactive response DNA-binding protein (TDP-43) is associated with several lethal neurodegenerative diseases, including amyotrophic lateral sclerosis and frontotemporal dementia. Cytoplasmic neuronal inclusions of TDP-43 are enriched in various fragments of the low-comp...

Full description

Bibliographic Details
Main Authors:	Jayakrishna Shenoy, Alons Lends, Mélanie Berbon, Muhammed Bilal, Nadia El Mammeri, Mathilde Bertoni, Ahmad Saad, Estelle Morvan, Axelle Grélard, Sophie Lecomte, François-Xavier Theillet, Alexander K. Buell, Brice Kauffmann, Birgit Habenstein, Antoine Loquet
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Molecular Biosciences
Subjects:	TDP-43 amyotrophic lateral sclerosis frontotemporal dementia amyloid polymorphism solid-state NMR
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2023.1148302/full

Similar Items

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
by: Sarah Pickles, et al.
Published: (2022-07-01)

Mechanisms of TDP-43 Proteinopathy Onset and Propagation
by: Han-Jou Chen, et al.
Published: (2021-06-01)

Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
by: Luigi Fiondella, et al.
Published: (2023-04-01)

TDP-43 Proteinopathy Specific Biomarker Development
by: Isabell Cordts, et al.
Published: (2023-02-01)

The Role of TDP-43 in Military-Relevant TBI and Chronic Neurodegeneration
by: Lanier Heyburn, et al.
Published: (2019-06-01)

Progranulin haploinsufficiency mediates cytoplasmic TDP-43 aggregation with lysosomal abnormalities in human microglia
by: Wonjae Sung, et al.
Published: (2024-02-01)

Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10
by: Tian Liu, et al.
Published: (2022-07-01)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
by: Rachel Atkinson, et al.
Published: (2021-02-01)

Distinct Phospho-TDP-43 brain distribution in two cases of FTD, one associated with ALS
by: Álvaro C.B. Guedes, et al.

Understanding In Vitro Pathways to Drug Discovery for TDP-43 Proteinopathies
by: Hei W. A. Cheng, et al.
Published: (2022-11-01)

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
by: Britt A. Berning, et al.
Published: (2019-04-01)

Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics?
by: Merel O. Mol, et al.
Published: (2021-09-01)

Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
by: Rachel H. Tan, et al.
Published: (2023-11-01)

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations
by: Kocerha Jannet, et al.
Published: (2011-10-01)

Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies
by: Shunsuke Koga, et al.
Published: (2023-07-01)

A panel of TDP-43-regulated splicing events verifies loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue
by: Maize C. Cao, et al.
Published: (2023-09-01)

TDP-43 is a ubiquitylation substrate of the SCFcyclin F complex
by: Stephanie L. Rayner, et al.
Published: (2022-06-01)

Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies
by: Laetitia Miguel, et al.
Published: (2011-02-01)

Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
by: Alba Cervantes González, et al.
Published: (2022-04-01)

Alterations in stress granule dynamics driven by TDP-43 and FUS: A link to pathological inclusions in ALS?
by: Anais eAulas, et al.
Published: (2015-10-01)

Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants
by: Lalitha Venkataraman, et al.
Published: (2020-09-01)

Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD)
by: Guinevere F. Lourenco, et al.
Published: (2015-10-01)

Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration
by: Ahmed Yousef, et al.
Published: (2017-09-01)

Body Complexion and Circulating Lipids in the Risk of TDP-43 Related Disorders
by: Noelia Esteban-García, et al.
Published: (2022-03-01)

Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy
by: Bilal Khalil, et al.
Published: (2022-12-01)

Distinct molecular patterns of TDP-43 pathology in Alzheimer’s disease: relationship with clinical phenotypes
by: Sandra O. Tomé, et al.
Published: (2020-04-01)

Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration
by: Laura M. Taylor, et al.
Published: (2018-02-01)

Transcriptomopathies of pre- and post-symptomatic frontotemporal dementia-like mice with TDP-43 depletion in forebrain neurons
by: Lien-Szu Wu, et al.
Published: (2019-03-01)

A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALS
by: Marc Shenouda, et al.
Published: (2022-06-01)

Loss of TDP-43 function contributes to genomic instability in amyotrophic lateral sclerosis
by: Minggang Fang, et al.
Published: (2023-10-01)

Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotype
by: Kasper Katisko, et al.
Published: (2022-10-01)

Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD
by: Tariq Afroz, et al.
Published: (2023-04-01)

Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice
by: Irene Santos-García, et al.
Published: (2023-05-01)

Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo
by: Henrick Riemenschneider, et al.
Published: (2023-07-01)

ATP-binding cassette transporter expression is widely dysregulated in frontotemporal dementia with TDP-43 inclusions
by: Jared S. Katzeff, et al.
Published: (2022-11-01)

Early cognitive/social deficits and late motor phenotype in conditional wild-type TDP-43 transgenic mice.
by: Julio Armando Alfieri, et al.
Published: (2016-12-01)

Aberrant TDP‐43 phosphorylation: a key wind gap from TDP‐43 to TDP‐43 proteinopathy
by: Zi‐Qi Huang, et al.
Published: (2021-06-01)

Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD
by: Alistair Wood, et al.
Published: (2021-04-01)

TDP-43 Pathology in Alzheimer’s Disease
by: Axel Meneses, et al.
Published: (2021-12-01)

Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice
by: Claudia Gonzalo-Consuegra, et al.
Published: (2024-05-01)